🔎 Trials Near Me

Dachaigh › Galar cealla corraich › Sgìre Cholumbia › Washington

Sgrùdaidhean clionaigeach Galar cealla corraich ann an Washington, DC

Tha 20 sgrùdaidhean airson Galar cealla corraich a’ lorg phàirtichean aig làraichean ann agus timcheall air Washington (taobh a-staigh mu 30 mìle). Fosglaidh sgrùdadh gus faicinn cò as urrainn pàirt a ghabhail agus mar a chuireas tu fios air an sgioba.

Teacsa sgrùdaidh oifigeil (Beurla)

A’ fastadh airson sgrùdadh an seo? Seall e aig mullach na duilleige seo — $99 airson 30 latha →

Collection of Human Biospecimens for Basic and Clinical Research Into Globin Variants

A’ fastadhSgrùdadh amharcFàilte do shaor-thoilich fhallain
  • National Institutes of Health Clinical Center, Bethesda · 7 mìle air falbh
Aoisean 18 gu 70 · Gach gnè · Air ùrachadh 2 Dàmh 2026 · NCT03937817

Blood Sampling for Research Related to Sickle Cell Disease

A’ fastadhSgrùdadh amharcFàilte do shaor-thoilich fhallain
  • National Institutes of Health Clinical Center, Bethesda · 7 mìle air falbh
Aoisean 18 gu 100 · Gach gnè · Air ùrachadh 29 Sult 2026 · NCT00542230

A Study to Investigate the Efficacy and Safety of Crizanlizumab (5 mg/kg) Compared With Placebo in Adolescent and Adult Sickle Cell Disease Patients Who Experience Frequent Vaso-Occlusive Crises (SPARKLE)

A’ fastadhÌre 3
  • Childrens National Hospital, Washington D.C.
Aoisean 12 gu 100 · Gach gnè · Air ùrachadh 28 Sult 2026 · NCT06439082

Determination of Red Cell Survival in Sickle Cell Disease and Other Hemoglobinopathies Using Biotin Labeling

A’ fastadhÌre 1 tràth
  • National Institutes of Health Clinical Center, Bethesda · 7 mìle air falbh
Aoisean 18 gu 100 · Gach gnè · Air ùrachadh 28 Sult 2026 · NCT06313398

Dietary Intake and Dietary Behaviors in Adults With Sickle Cell Disease

A’ fastadhSgrùdadh amharc
  • National Institutes of Health Clinical Center, Bethesda · 7 mìle air falbh
Aoisean 18 gu 120 · Gach gnè · Air ùrachadh 18 Sult 2026 · NCT05170412

Study to Evaluate the Safety and Tolerability of Escalating Doses of Fostamatinib in Subjects With Stable Sickle Cell Disease

A’ fastadhÌre 1
  • National Institutes of Health Clinical Center, Bethesda · 7 mìle air falbh
Aoisean 18 gu 65 · Gach gnè · Air ùrachadh 17 Sult 2026 · NCT05904093

A Study to Evaluate How Well Etavopivat Works in People With Sickle Cell Disease

A’ fastadhÌre 3
  • Childrens National Medical Ctr, Washington D.C.
  • MedStar Hlth Res Institute, Washington D.C.
Aoisean 12 agus nas sine · Gach gnè · Air ùrachadh 17 Sult 2026 · NCT06612268

Study to Understand the Genetic Risk of Developing an Immune Response After Blood Transfusions Among Individuals With Sickle Cell Disease

A’ fastadhSgrùdadh amharc
  • National Institutes of Health Clinical Center, Bethesda · 7 mìle air falbh
Aoisean 2 gu 99 · Gach gnè · Air ùrachadh 11 Sult 2026 · NCT06944067

SCD Stem Cell Mobilization and Apheresis Using Motixafortide

A’ fastadhÌre 1
  • National Heart, Blood and Lung Institute-Cellular and Molecular Therapy Branch, Bethesda · 7 mìle air falbh
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 8 Sult 2026 · NCT06442761

Partial Stem Cell Transplant for Sickle Cell Disease From Matched Donors

A’ fastadhÌre 1/2
  • National Institutes of Health Clinical Center, Bethesda · 7 mìle air falbh
Aoisean 4 gu 65 · Gach gnè · Air ùrachadh 4 Sult 2026 · NCT07599176

Escalating Doses of VAS-101 in Subjects With Stable Sickle Cell Disease

A’ fastadhÌre 1
  • National Institutes of Health Clinical Center, Bethesda · 7 mìle air falbh
Aoisean 18 gu 90 · Gach gnè · Air ùrachadh 24 Lùna 2026 · NCT07566494

ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders

A’ fastadhSgrùdadh amharc
  • Georgetown University, Washington D.C.
  • Children's National Hemophilia Center, Washington D.C.
Gach aois · Gach gnè · Air ùrachadh 17 Lùna 2026 · NCT04398628

Safety of Anumigilimab (CSL324) in Adults With Sickle Cell Disease (SCD)

A’ fastadhÌre 2
  • Center for Cancer and Blood Disorders, Bethesda · 7 mìle air falbh
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 5 Lùna 2026 · NCT07224360

Cooperative Assessment of Late Effects for SCD Curative Therapies

A’ fastadhSgrùdadh amharc
  • Children's National Medical Center, Washington D.C.
  • National Institutes of Health Clinical Center, Bethesda · 7 mìle air falbh
Aoisean 4 gu 65 · Gach gnè · Air ùrachadh 27 Iuch 2026 · NCT05153967

Comparing the Effectiveness of Matched Related Donor Hematopoietic Stem Cell Transplantation to Disease Modifying Therapy in Pediatric Patients With Sickle Cell Disease

A’ fastadhSgrùdadh amharc
  • Children's National Hospital (MRD-HCT), Washington D.C.
Aoisean 3 gu 20 · Gach gnè · Air ùrachadh 4 Ògmh 2026 · NCT06941389

Intravenous L-Citrulline for Vaso-occlusive Pain Episode in Sickle Cell Disease

A’ fastadhÌre 2
  • Children's National Hospital, Washington D.C.
Aoisean 4 gu 21 · Gach gnè · Air ùrachadh 13 Gibl 2026 · NCT06635902

Minimizing Toxicity in HLA-identical Sibling Donor Transplantation for Children With Sickle Cell Disease

A’ fastadhÌre 2
  • Children's National Health System, Washington D.C.
Aoisean 2 gu 25 · Gach gnè · Air ùrachadh 10 Màrt 2026 · NCT03587272

Sickle Cell Disease Transplant Using a Nonmyeloablative Approach for Patients With Anti-donor Red Cell Antibody

A’ fastadhÌre 2
  • Children's National Hospital, Washington D.C.
Aoisean 2 gu 25 · Gach gnè · Air ùrachadh 26 Sult 2025 · NCT06358638

Advancing Feasibility and Acceptability of Digital Cognitive Rehabilitation in Sickle Cell Disease

A’ fastadh
  • Children's National Hospital, Washington D.C.
Aoisean 7 gu 16 · Gach gnè · Air ùrachadh 13 Gearr 2025 · NCT06770010

Feasibility and Efficacy of Attentional-Control Training in Sickle Cell Disease

A’ fastadh
  • Children's National Hospital, Washington D.C.
Aoisean 8 gu 16 · Gach gnè · Air ùrachadh 10 Faoi 2025 · NCT05099874

Sgrùdaidhean Galar cealla corraich ann am bailtean eile

Sgrùdaidhean eile ann an Washington

Bho ClinicalTrials.gov, dàta air a thogail 6 Dàmh 2026. Bidh gach sgrùdadh a’ suidheachadh a chuidi fhèin; bidh an sgioba sgrùdaidh a’ co-dhùnadh cò as urrainn pàirt a ghabhail.